Fight On Tap Over Firms' $4M Fee Bid In CytoDyn Suit Deal
As a Delaware vice chancellor is set to consider a proposed stockholder suit settlement that will require five directors of life sciences venture CytoDyn Inc. to forfeit certain awards, three firms...To view the full article, register now.
Already a subscriber? Click here to view full article